TickerFactsScreenerDevelopers

BioRestorative Therapies, Inc. (BRTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $45.4K2011: $17.8K2012: $2.5K2013: $11.2K2014: $168.4K2015: $408.1K2016: $188.8K2017: $3.6K2018: $12.9K2019: $35.6K2021: $30.7K2022: $265.2K2023: $171.0K2024: $106.2K2025: $116.1K$116.1K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$116.1K+9.3%
2024$106.2K-37.9%
2023$171.0K-35.5%
2022$265.2K+765.1%
2021$30.7K—
2019$35.6K+176.9%
2018$12.9K+255.8%
2017$3.6K-98.1%
2016$188.8K-53.7%
2015$408.1K+142.4%
2014$168.4K+1408.7%
2013$11.2K+340.6%
2012$2.5K-85.7%
2011$17.8K-60.8%
2010$45.4K—